Artifactual Depression of Serum Glutamic Oxaloacetic Transaminase by Metronidazole
AUTOR(ES)
Rissing, J. Peter
RESUMO
Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole therapy. Metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352522Documentos Relacionados
- A SOURCE OF ERROR IN SERUM GLUTAMIC-OXALOACETIC TRANSAMINASE DETERMINATION
- Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related.
- Enhancement of Glutamic-Pyruvic Transaminase Activity in Leptospirae by Addition of Rabbit Serum
- SERUM GLUTAMIC OXALACETIC TRANSAMINASE LEVELS IN DIPHTHERITIC MYOCARDITIS
- Control material for oxalo-acetic transaminase determination
